Details of the Drug Reposition

General Information of This Drug (ID: DMDT5WM)

Drug Name
KPAX002   DMDT5WM

Information on Drug Reposition of This Drug

Molecular Interaction Atlas (MIA)
1 Phase 2 Indication(s)
Indication Name Indication ID ICD-11 Status REF
Alzheimer disease DISF8S70 8A20 Phase 2 [1]
------------------------------------------------------------------------------------
2 Clinical trial Indication(s)
Indication Name Indication ID ICD-11 Status REF
Parkinson disease DISQVHKL 8A00.0 Clinical trial [2]
Amyotrophic lateral sclerosis DISF7HVM 8B60.0 Clinical trial [2]
------------------------------------------------------------------------------------

References

1 Clinical pipeline report, company report or official report of the Pharmaceutical Research and Manufacturers of America (PhRMA)
2 Clinical pipeline report, company report or official report of the Pharmaceutical Research and Manufacturers of America (PhRMA)